Malina Jasamai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Malina Jasamai has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Norsyahida Mohd Fauzi
Centre for Drug & Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz
4 shared publications- Claire Simons
School of Pharmacy & Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK
2 shared publications Endang Kumolosasi
Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia
2 shared publications- Endang Kumolosasi
Drug and Herbal Research Centre, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
2 shared publications - Ibrahim Jantan
Institute of Systems Biology (INBIOSIS) Universiti Kebangsaan Malaysia (UKM) Bangi Malaysia
2 shared publications Khairana Husain
Centre for Drug & Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz
2 shared publications
Latest Publications
- 2 November 2026
- Published by Taylor & Francis in Journal of the American Nutrition Association
- p. 1-12
Attenuation of Angiotensin II- Induced Cardiomyocyte Hypertrophy by Moringa oleifera Lam. extract, Fractions and Bioactive Constituents: Cell Size Analysis and Molecular Docking
Cardiac hypertrophy, also known as left ventricular hypertrophy (LVH), is a compensatory condition in which cardiomyocytes act through adaptive mechanisms when exposed to hemodynamic stress, to mai...
- 2 November 2026
- Published by Taylor & Francis in Journal of the American Nutrition Association
- p. 1-12
Attenuation of Angiotensin II- Induced Cardiomyocyte Hypertrophy by Moringa oleifera Lam. extract, Fractions and Bioactive Constituents: Cell Size Analysis and Molecular Docking
Cardiac hypertrophy, also known as left ventricular hypertrophy (LVH), is a compensatory condition in which cardiomyocytes act through adaptive mechanisms when exposed to hemodynamic stress, to mai...
- Open Access
- 30 August 2026
- Published by Persatuan Biologi Gunaan Malaysia in Malaysian Applied Biology
- Vol. 55 (3) , 41-52
The Therapeutic Potentials of Malaysian Medicinal Plants for Cardiovascular Diseases: A Review
Cardiovascular diseases are among the most common diseases around the world with a considerably high rate of mortality. In view of this, multiple approaches have been proposed, especially in exploiting the potential of herbal plants due to their availability, accessibility and medicinal values. This review was conducted based on 16 medicinal herbs available in Malaysia as listed in the Malaysian Herbal Monograph. The aim was to study their effects on the alleviation of cardiovascular diseases, to analyse the relationship between the phytochemical compounds of herbal plants in relation to cardiovascular diseases and to review their underlying mechanism of action. The medicinal plants are organised based on their effects on alleviating cardiovascular diseases either directly or indirectly through reduction of cardiovascular disease risk factors, such as antihyperlipidemic, vasodilatory effects, cardioprotective and anticoagulant effects. Both in vivo and in vitro studies are included in this review to demonstrate the scientific value of related plants in cardiovascular diseases. In conclusion, many studies have identified a diversity of herbal plants in Malaysia to possess cardiovascular-relieving activities. Further studies can be conducted to develop these plants for cardiovascular disease treatment or prevention.
- 30 August 2026
- Published by Persatuan Biologi Gunaan Malaysia in Malaysian Applied Biology
- Vol. 55 (3) , 41-52
Open AccessThe Therapeutic Potentials of Malaysian Medicinal Plants for Cardiovascular Diseases: A Review
Cardiovascular diseases are among the most common diseases around the world with a considerably high rate of mortality. In view of this, multiple approaches have been proposed, especially in exploiting the potential of herbal plants due to their availability, accessibility and medicinal values. This review was conducted based on 16 medicinal herbs available in Malaysia as listed in the Malaysian Herbal Monograph. The aim was to study their effects on the alleviation of cardiovascular diseases, to analyse the relationship between the phytochemical compounds of herbal plants in relation to cardiovascular diseases and to review their underlying mechanism of action. The medicinal plants are organised based on their effects on alleviating cardiovascular diseases either directly or indirectly through reduction of cardiovascular disease risk factors, such as antihyperlipidemic, vasodilatory effects, cardioprotective and anticoagulant effects. Both in vivo and in vitro studies are included in this review to demonstrate the scientific value of related plants in cardiovascular diseases. In conclusion, many studies have identified a diversity of herbal plants in Malaysia to possess cardiovascular-relieving activities. Further studies can be conducted to develop these plants for cardiovascular disease treatment or prevention.
- 13 August 2026
- Published by World Scientific Pub Co Pte Ltd in International Journal of Nanoscience
Revolutionizing Disease Management: Harnessing the Synergy of Nanotechnology and Phytotherapy for Therapeutic Excellence
Nanophytotherapeutics, an amalgamation of nanotechnology and phytotherapeutics, signifies a transformative paradigm in disease management. This comprehensive review explores the vast landscape of nanophytotherapeutics, focusing on its applications in diverse medical domains, including cancer, cardiovascular diseases, neurological disorders, gastrointestinal issues, dermal disorders and urogenital disorders. The synergistic integration of precisely engineered nanoparticles with phytotherapeutic agents exhibits promising potential in targeted drug delivery, enhancing bioavailability and minimizing side effects. While the field holds remarkable promise, challenges such as toxicity understanding, large-scale production, accessibility and affordability necessitate careful consideration. The review emphasizes the imperative need for robust evidence, continued research and comprehensive training for healthcare providers to ensure the ethical and successful implementation of these groundbreaking technologies in healthcare. Looking forward, recent advancements and emerging trends underscore a promising future for nanomedicine, envisioning improved therapeutic outcomes and an enhanced quality of life for patients globally. As research progresses, nanophytotherapeutics stands poised to revolutionize disease management, offering safer and more effective alternatives to conventional treatments.
- 13 August 2026
- Published by World Scientific Pub Co Pte Ltd in International Journal of Nanoscience
Revolutionizing Disease Management: Harnessing the Synergy of Nanotechnology and Phytotherapy for Therapeutic Excellence
Nanophytotherapeutics, an amalgamation of nanotechnology and phytotherapeutics, signifies a transformative paradigm in disease management. This comprehensive review explores the vast landscape of nanophytotherapeutics, focusing on its applications in diverse medical domains, including cancer, cardiovascular diseases, neurological disorders, gastrointestinal issues, dermal disorders and urogenital disorders. The synergistic integration of precisely engineered nanoparticles with phytotherapeutic agents exhibits promising potential in targeted drug delivery, enhancing bioavailability and minimizing side effects. While the field holds remarkable promise, challenges such as toxicity understanding, large-scale production, accessibility and affordability necessitate careful consideration. The review emphasizes the imperative need for robust evidence, continued research and comprehensive training for healthcare providers to ensure the ethical and successful implementation of these groundbreaking technologies in healthcare. Looking forward, recent advancements and emerging trends underscore a promising future for nanomedicine, envisioning improved therapeutic outcomes and an enhanced quality of life for patients globally. As research progresses, nanophytotherapeutics stands poised to revolutionize disease management, offering safer and more effective alternatives to conventional treatments.
- Open Access
Gynura procumbens (Lour.) Merr. and Its Active Compound Attenuate Oleic Acid-Induced Hepatocyte Steatosis and Modulate Cholesterol Metabolism-Related Gene Expression
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterised by excessive lipid accumulation in hepatocytes and often accompanied by dyslipidaemia. Gynura procumbens, a medicinal plant native to Southeast Asia, exhibits lipid-lowering and hepatoprotective properties. However, its effects on hepatic lipid accumulation and cholesterol metabolism-related gene regulation remain unclear. This study evaluated the effects of G. procumbens extract (GPCE) and stigmasterol on oleic acid-induced hepatocyte steatosis and cholesterol metabolism-related gene expression. GPCE was assessed for HMG-CoA reductase (HMGCR) inhibition, lipid accumulation, and expression of cholesterol metabolism-related genes (HMGCR, SREBP2, LDLR, and PCSK9). Bioassay-guided fractionation identified stigmasterol as a constituent of the highly active fractions and its structure was characterised by LC-TOF-MS and NMR. GPCE and stigmasterol inhibited HMGCR activity by 86.31 ± 5.3% and 56.59 ± 7.6%, respectively. Both treatments reduced lipid accumulation in hepatocytes and modulated the mRNA expression of selected cholesterol homeostasis-related genes, including transcriptional downregulation of SREBP2 and PCSK9. These findings suggest that G. procumbens possesses lipid-lowering activity and that stigmasterol may represent one of the bioactive constituents contributing to its observed biological effects. Further studies involving protein level validation, functional assays and in vivo studies are warranted to fully elucidate the mechanisms and establish the biological relevance of these findings in MASLD.
Open AccessGynura procumbens (Lour.) Merr. and Its Active Compound Attenuate Oleic Acid-Induced Hepatocyte Steatosis and Modulate Cholesterol Metabolism-Related Gene Expression
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterised by excessive lipid accumulation in hepatocytes and often accompanied by dyslipidaemia. Gynura procumbens, a medicinal plant native to Southeast Asia, exhibits lipid-lowering and hepatoprotective properties. However, its effects on hepatic lipid accumulation and cholesterol metabolism-related gene regulation remain unclear. This study evaluated the effects of G. procumbens extract (GPCE) and stigmasterol on oleic acid-induced hepatocyte steatosis and cholesterol metabolism-related gene expression. GPCE was assessed for HMG-CoA reductase (HMGCR) inhibition, lipid accumulation, and expression of cholesterol metabolism-related genes (HMGCR, SREBP2, LDLR, and PCSK9). Bioassay-guided fractionation identified stigmasterol as a constituent of the highly active fractions and its structure was characterised by LC-TOF-MS and NMR. GPCE and stigmasterol inhibited HMGCR activity by 86.31 ± 5.3% and 56.59 ± 7.6%, respectively. Both treatments reduced lipid accumulation in hepatocytes and modulated the mRNA expression of selected cholesterol homeostasis-related genes, including transcriptional downregulation of SREBP2 and PCSK9. These findings suggest that G. procumbens possesses lipid-lowering activity and that stigmasterol may represent one of the bioactive constituents contributing to its observed biological effects. Further studies involving protein level validation, functional assays and in vivo studies are warranted to fully elucidate the mechanisms and establish the biological relevance of these findings in MASLD.
- Open Access
- 22 September 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Pharmacy
- p. 469–478
Moringa Oleifera Lam Leaves Extract and Its Compounds Effect on The Intracellular Calcium Release in Human Aortic Smooth Muscle Cells
Moringa oleifera leaves have been scientifically shown lower blood pressure but the mechanism of action on this is achieved has not been fully explored. Intracellular calcium release is a fundamental cellular process linked to vascular function and modulation of this process can have significant implications for cardiovascular health. The blocking effects of calcium influx and release by Moringa oleifera Lam leaf extract and its compounds on the human aortic smooth muscle cells (HAoSMCs) were studied. The cell viability assay was carried out to determine the concentrations of M. oleifera Lam leaf extract and its compounds for the assay. Test compounds (amlodipine, chlorogenic acid, gallic acid, kaempferol, M. oleifera leaf extract, quercetin and vicenin-2) were incubated with Quin-2-AM in the presence and absence of extracellular calcium (Ca2+) and with the addition of caffeine and potassium (K+) in HAoSMCs. Following treatments with the test compounds, the influx of extracellular Ca2+ into the cytosol of HAoSMCs was significantly inhibited (p <0.001). The test compounds significantly (p <0.001) decreased the concentration of cytosolic Ca2+ induced by K+ depolarisation. The test compounds also significantly (p <0.001) affected the intracellular Ca2+metabolism, regulated by the caffeine-sensitive storage site in HAoSMCs. No synergistic effect on the decreasing of cytosolic Ca2+ level was observed when the test compounds were used in combination with amlodipine. M. oleifera Lam leaf extract and its compounds may act as Ca2+channel blockers (CCBs) and there is also a possibility of interactions between the test compounds and amlodipine.
- 22 September 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Pharmacy
- p. 469–478
Open AccessMoringa Oleifera Lam Leaves Extract and Its Compounds Effect on The Intracellular Calcium Release in Human Aortic Smooth Muscle Cells
Moringa oleifera leaves have been scientifically shown lower blood pressure but the mechanism of action on this is achieved has not been fully explored. Intracellular calcium release is a fundamental cellular process linked to vascular function and modulation of this process can have significant implications for cardiovascular health. The blocking effects of calcium influx and release by Moringa oleifera Lam leaf extract and its compounds on the human aortic smooth muscle cells (HAoSMCs) were studied. The cell viability assay was carried out to determine the concentrations of M. oleifera Lam leaf extract and its compounds for the assay. Test compounds (amlodipine, chlorogenic acid, gallic acid, kaempferol, M. oleifera leaf extract, quercetin and vicenin-2) were incubated with Quin-2-AM in the presence and absence of extracellular calcium (Ca2+) and with the addition of caffeine and potassium (K+) in HAoSMCs. Following treatments with the test compounds, the influx of extracellular Ca2+ into the cytosol of HAoSMCs was significantly inhibited (p <0.001). The test compounds significantly (p <0.001) decreased the concentration of cytosolic Ca2+ induced by K+ depolarisation. The test compounds also significantly (p <0.001) affected the intracellular Ca2+metabolism, regulated by the caffeine-sensitive storage site in HAoSMCs. No synergistic effect on the decreasing of cytosolic Ca2+ level was observed when the test compounds were used in combination with amlodipine. M. oleifera Lam leaf extract and its compounds may act as Ca2+channel blockers (CCBs) and there is also a possibility of interactions between the test compounds and amlodipine.
- Open Access
- 7 May 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 214-227
DESIGN AND COMPUTATIONAL ANALYSIS OF NEW ISATIN-IMINE HYBRIDS AS SELECTIVE HDAC6 INHIBITORS
Objective: Emerging evidence highlights the critical role of Histone Deacetylase (HDAC) 6 in various pathologies, including cancer and neurodegenerative diseases. Therefore, we sought to computationally study new isatin-imine hybrid compounds to predict their Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profiles and binding mode with HDAC6 through docking and molecular dynamics simulations. Methods: ADMET and drug-likeness properties of target compounds were predicted using ADMETlab 3.0. Molecular docking was conducted using Autodock4Zn embedded in Amdock v1.5.2 against HDAC6, HDAC8, and HDAC2. Utilizing Newton's equations of motion in conjunction with the Desmond package from the Schrödinger software suite, a molecular dynamics simulation of 100 nanoseconds was conducted to investigate protein-ligand interactions at the atomic level. Results: All compounds exhibited favorable physicochemical characteristics and met drug-likeness criteria, showing good absorption profile, high protein binding (except Km73 and Km74), and Human Liver Microsomal enzyme stability. Three compounds (Km66, Km68, and Km74) had low plasma clearance, while Km69, Km72, and Km73 had moderate clearance. Compounds were predicted to have favorable toxicity profiles. In docking studies on HDAC6, all compounds showed higher binding affinities (-7.44 to-10.69 Kcal/mol) than the reference compounds SAHA and Nexturastat A. For HDAC2, all compounds had a lower binding affinity than for HDAC6, except Km68, which showed a higher affinity for HDAC2 (-10.61 vs.-9.23 Kcal/mol). Km68 and Km69 demonstrated stable binding modes in molecular dynamics simulations, while Km68 showed some deviations. Conclusion: Our findings indicate that all compounds demonstrate favorable ADMET profiles, binding affinities, and selectivity towards HDAC6. Their predicted binding affinity has outperformed that of reference compounds, including SAHA and HDAC6-selective nexturastat A. This suggests that these compounds have the potential to be promising candidates for selective inhibition of HDAC6, thereby opening up new possibilities in drug development.
- 7 May 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 214-227
Open AccessDESIGN AND COMPUTATIONAL ANALYSIS OF NEW ISATIN-IMINE HYBRIDS AS SELECTIVE HDAC6 INHIBITORS
Objective: Emerging evidence highlights the critical role of Histone Deacetylase (HDAC) 6 in various pathologies, including cancer and neurodegenerative diseases. Therefore, we sought to computationally study new isatin-imine hybrid compounds to predict their Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profiles and binding mode with HDAC6 through docking and molecular dynamics simulations. Methods: ADMET and drug-likeness properties of target compounds were predicted using ADMETlab 3.0. Molecular docking was conducted using Autodock4Zn embedded in Amdock v1.5.2 against HDAC6, HDAC8, and HDAC2. Utilizing Newton's equations of motion in conjunction with the Desmond package from the Schrödinger software suite, a molecular dynamics simulation of 100 nanoseconds was conducted to investigate protein-ligand interactions at the atomic level. Results: All compounds exhibited favorable physicochemical characteristics and met drug-likeness criteria, showing good absorption profile, high protein binding (except Km73 and Km74), and Human Liver Microsomal enzyme stability. Three compounds (Km66, Km68, and Km74) had low plasma clearance, while Km69, Km72, and Km73 had moderate clearance. Compounds were predicted to have favorable toxicity profiles. In docking studies on HDAC6, all compounds showed higher binding affinities (-7.44 to-10.69 Kcal/mol) than the reference compounds SAHA and Nexturastat A. For HDAC2, all compounds had a lower binding affinity than for HDAC6, except Km68, which showed a higher affinity for HDAC2 (-10.61 vs.-9.23 Kcal/mol). Km68 and Km69 demonstrated stable binding modes in molecular dynamics simulations, while Km68 showed some deviations. Conclusion: Our findings indicate that all compounds demonstrate favorable ADMET profiles, binding affinities, and selectivity towards HDAC6. Their predicted binding affinity has outperformed that of reference compounds, including SAHA and HDAC6-selective nexturastat A. This suggests that these compounds have the potential to be promising candidates for selective inhibition of HDAC6, thereby opening up new possibilities in drug development.
- Open Access
- 27 October 2023
- Published by Springer Nature in Research Square
Moringa oleifera Lam leaves extract and its compounds effect on the intracellular calcium release in human aortic smooth muscle cells
The calcium influx and release blocking effects of Moringa oleifera Lam leaf extract and its compounds on the human aortic smooth muscle cells (HAoSMCs) were studied. The cell viability assay was carried out to determine the concentrations of M. oleifera Lam leaf extract and its compounds for the assay. The test compounds in HAoSMCs were incubated with Quin-2-AM in the presence and absence of extracellular calcium (Ca2+) and with the addition of caffeine and potassium (K+). Following treatments with amlodipine, chlorogenic acid, gallic acid, kaempferol, M. oleifera leaf extract, quercetin and vicenin-2, the influx of extracellular Ca2+ into the cytosol of HAoSMCs was significantly inhibited (p 2+ induced by K+ depolarisation. The test compounds also significantly (p 2+ metabolism, regulated by the caffeine-sensitive storage site in HAoSMCs. No synergistic effect on the decreasing cytosolic Ca2+ level was observed when the test compounds were used in combination with amlodipine. M. oleifera Lam leaf extract and its compounds may act as Ca2+ channel blockers (CCBs) and also possibility of interactions between the test compounds and amlodipine.
- 27 October 2023
- Published by Springer Nature in Research Square
Open AccessMoringa oleifera Lam leaves extract and its compounds effect on the intracellular calcium release in human aortic smooth muscle cells
The calcium influx and release blocking effects of Moringa oleifera Lam leaf extract and its compounds on the human aortic smooth muscle cells (HAoSMCs) were studied. The cell viability assay was carried out to determine the concentrations of M. oleifera Lam leaf extract and its compounds for the assay. The test compounds in HAoSMCs were incubated with Quin-2-AM in the presence and absence of extracellular calcium (Ca2+) and with the addition of caffeine and potassium (K+). Following treatments with amlodipine, chlorogenic acid, gallic acid, kaempferol, M. oleifera leaf extract, quercetin and vicenin-2, the influx of extracellular Ca2+ into the cytosol of HAoSMCs was significantly inhibited (p 2+ induced by K+ depolarisation. The test compounds also significantly (p 2+ metabolism, regulated by the caffeine-sensitive storage site in HAoSMCs. No synergistic effect on the decreasing cytosolic Ca2+ level was observed when the test compounds were used in combination with amlodipine. M. oleifera Lam leaf extract and its compounds may act as Ca2+ channel blockers (CCBs) and also possibility of interactions between the test compounds and amlodipine.
- Open Access
- 22 December 2020
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 29 (1) , 73-84
Induction of cell death and modulation of Annexin A1 by phytoestrogens in human leukemic cell lines
Phytoestrogens are polyphenolic plant compounds which are structurally similar to the endogenous mammalian estrogen, 17β-estradiol. Annexin A1 (ANXA1) is an endogenous protein which inhibits cyclo-oxygenase 2 (COX-2) and phospholipase A2, signal transduction, DNA replication, cell transformation, and mediation of apoptosis.
- 22 December 2020
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 29 (1) , 73-84
Open AccessInduction of cell death and modulation of Annexin A1 by phytoestrogens in human leukemic cell lines
Phytoestrogens are polyphenolic plant compounds which are structurally similar to the endogenous mammalian estrogen, 17β-estradiol. Annexin A1 (ANXA1) is an endogenous protein which inhibits cyclo-oxygenase 2 (COX-2) and phospholipase A2, signal transduction, DNA replication, cell transformation, and mediation of apoptosis.
- Open Access
Sperm Proteomics Analysis of Diabetic Induced Male Rats as Influenced by Ficus carica Leaf Extract
Diabetes mellitus is shown to bring negative effects on male reproductive health due to long-term effects of insulin deficiency or resistance and increased oxidative stress. Ficus carica (FC), an herbal plant, known to have high antioxidant activity and antidiabetic properties, has been used traditionally to treat diabetes. The objective of this study is to determine the potential of the FC leaf extract in improving sperm quality of streptozotocin (STZ) induced diabetic male rats from proteomics perspective. A total of 20 male rats were divided into four groups; normal (nondiabetic rats), negative control (diabetic rats without treatment), positive control (diabetic rats treated with 300 mg/kg metformin), and FC group (diabetic rats treated with 400 mg/kg FC extract). The treatments were given via oral gavage for 21 consecutive days. The fasting blood glucose (FBG) level of FC treated group demonstrated a significant (p < 0.05) decrease compared to negative group after 21 days of treatment, as well as a significant (p < 0.05) increase in the sperm quality parameters compared to negative group. Sperm proteomics analysis on FC treated group also exhibited the increase of total protein expression especially the proteins related to fertility compared to negative group. In conclusion, this study clearly justified that FC extract has good potential as antihyperglycemic and profertility agent that may be beneficial for male diabetic patients who have fertility problems.
Open AccessSperm Proteomics Analysis of Diabetic Induced Male Rats as Influenced by Ficus carica Leaf Extract
Diabetes mellitus is shown to bring negative effects on male reproductive health due to long-term effects of insulin deficiency or resistance and increased oxidative stress. Ficus carica (FC), an herbal plant, known to have high antioxidant activity and antidiabetic properties, has been used traditionally to treat diabetes. The objective of this study is to determine the potential of the FC leaf extract in improving sperm quality of streptozotocin (STZ) induced diabetic male rats from proteomics perspective. A total of 20 male rats were divided into four groups; normal (nondiabetic rats), negative control (diabetic rats without treatment), positive control (diabetic rats treated with 300 mg/kg metformin), and FC group (diabetic rats treated with 400 mg/kg FC extract). The treatments were given via oral gavage for 21 consecutive days. The fasting blood glucose (FBG) level of FC treated group demonstrated a significant (p < 0.05) decrease compared to negative group after 21 days of treatment, as well as a significant (p < 0.05) increase in the sperm quality parameters compared to negative group. Sperm proteomics analysis on FC treated group also exhibited the increase of total protein expression especially the proteins related to fertility compared to negative group. In conclusion, this study clearly justified that FC extract has good potential as antihyperglycemic and profertility agent that may be beneficial for male diabetic patients who have fertility problems.
- Open Access
- 11 December 2019
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 1-16
In vitro anti-allergic activity of Moringa oleifera Lam. extracts and their isolated compounds
Background: Moringa oleifera Lam. is a commonly used plant in herbal medicine and has various reported bioactivities such as antioxidant, antimicrobial, anticancer and antidiabetes. It is rich in nutrients and polyphenols. The plant also has been traditionally used for alleviating allergic conditions. This study was aimed to examine the anti-allergic activity of M. oleifera extracts and its isolated compounds. Method: M. oleifera leaves, seeds and pods were extracted with 80% of ethanol. Individual compounds were isolated using a column chromatographic technique and elucidated based on the nuclear magnetic resonance (NMR) and electrospray ionisation mass spectrometry (ESIMS) spectral data. The anti-allergic activity of the extracts, isolated compounds and ketotifen fumarate as a positive control was evaluated using rat basophilic leukaemia (RBL-2H3) cells for early and late phases of allergic reactions. The early phase was determined based on the inhibition of beta-hexosaminidase and histamine release; while the late phase was based on the inhibition of interleukin (IL-4) and tumour necrosis factor (TNF-α) release. Results: Two new compounds; ethyl-(E)–undec-6-enoate (1) and 3,5,6-trihydroxy-2-(2,3,4,5,6-pentahydroxyphenyl)-4H-chromen-4-one (2) together with six known compounds; quercetin (3), kaempferol (4), β-sitosterol-3-O-glucoside (5), oleic acid (6), glucomoringin (7), 2,3,4-trihydroxybenzaldehyde (8) and stigmasterol (9) were isolated from M. oleifera extracts. All extracts and the isolated compounds inhibited mast cell degranulation by inhibiting beta-hexosaminidase and histamine release, as well as the release of IL-4 and TNF-α at varying levels compared with ketotifen fumarate. Conclusion: The study suggested that M. oleifera and its isolated compounds potentially have an anti-allergic activity by inhibiting both early and late phases of allergic reactions.
- 11 December 2019
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 1-16
Open AccessIn vitro anti-allergic activity of Moringa oleifera Lam. extracts and their isolated compounds
Background: Moringa oleifera Lam. is a commonly used plant in herbal medicine and has various reported bioactivities such as antioxidant, antimicrobial, anticancer and antidiabetes. It is rich in nutrients and polyphenols. The plant also has been traditionally used for alleviating allergic conditions. This study was aimed to examine the anti-allergic activity of M. oleifera extracts and its isolated compounds. Method: M. oleifera leaves, seeds and pods were extracted with 80% of ethanol. Individual compounds were isolated using a column chromatographic technique and elucidated based on the nuclear magnetic resonance (NMR) and electrospray ionisation mass spectrometry (ESIMS) spectral data. The anti-allergic activity of the extracts, isolated compounds and ketotifen fumarate as a positive control was evaluated using rat basophilic leukaemia (RBL-2H3) cells for early and late phases of allergic reactions. The early phase was determined based on the inhibition of beta-hexosaminidase and histamine release; while the late phase was based on the inhibition of interleukin (IL-4) and tumour necrosis factor (TNF-α) release. Results: Two new compounds; ethyl-(E)–undec-6-enoate (1) and 3,5,6-trihydroxy-2-(2,3,4,5,6-pentahydroxyphenyl)-4H-chromen-4-one (2) together with six known compounds; quercetin (3), kaempferol (4), β-sitosterol-3-O-glucoside (5), oleic acid (6), glucomoringin (7), 2,3,4-trihydroxybenzaldehyde (8) and stigmasterol (9) were isolated from M. oleifera extracts. All extracts and the isolated compounds inhibited mast cell degranulation by inhibiting beta-hexosaminidase and histamine release, as well as the release of IL-4 and TNF-α at varying levels compared with ketotifen fumarate. Conclusion: The study suggested that M. oleifera and its isolated compounds potentially have an anti-allergic activity by inhibiting both early and late phases of allergic reactions.